questionsmedicales.fr
Phénomènes génétiques
Structures génétiques
Génome
Génome microbien
Génome viral
Génome viral : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Tests sérologiques
Tests moléculaires
Séquencement
Génome viral
Symptômes
Infection virale
Classification des virus
Acides nucléiques
Symptômes
5
Symptômes
Infection virale
Variabilité des symptômes
Virus
Évolution des symptômes
Réponse immunitaire
Asymptomatique
Infection virale
Prévention
5
Vaccins
Efficacité des vaccins
Santé publique
Surveillance épidémiologique
Masques
Transmission virale
Voyages
Propagation virale
Traitements
5
Antibiotiques
Infections virales
Antiviraux
Réplication virale
Traitements spécifiques
Virus
Vaccins
Prévention des infections
Complications
5
Complications
Infection virale
Traitement des complications
Soins de soutien
Fréquence des complications
État de santé
Personnes âgées
Risque de complications
Prévention des complications
Diagnostic précoce
Facteurs de risque
5
Facteurs de risque
Immunodépression
Mode de vie
Prévention des infections
Maladies chroniques
Système immunitaire
Voyages
Risque d'infection
Contacts étroits
Transmission virale
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Génome viral : Questions médicales les plus fréquentes",
"headline": "Génome viral : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Génome viral : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-18",
"dateModified": "2025-04-12",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Génome viral"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Génome microbien",
"url": "https://questionsmedicales.fr/mesh/D064349",
"about": {
"@type": "MedicalCondition",
"name": "Génome microbien",
"code": {
"@type": "MedicalCode",
"code": "D064349",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.358"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Gènes viraux",
"alternateName": "Genes, Viral",
"url": "https://questionsmedicales.fr/mesh/D005814",
"about": {
"@type": "MedicalCondition",
"name": "Gènes viraux",
"code": {
"@type": "MedicalCode",
"code": "D005814",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.358.840.500"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Gènes env",
"alternateName": "Genes, env",
"url": "https://questionsmedicales.fr/mesh/D015752",
"about": {
"@type": "MedicalCondition",
"name": "Gènes env",
"code": {
"@type": "MedicalCode",
"code": "D015752",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.358.840.500.172"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Gènes gag",
"alternateName": "Genes, gag",
"url": "https://questionsmedicales.fr/mesh/D015750",
"about": {
"@type": "MedicalCondition",
"name": "Gènes gag",
"code": {
"@type": "MedicalCode",
"code": "D015750",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.358.840.500.258"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Gènes précoces",
"alternateName": "Genes, Immediate-Early",
"url": "https://questionsmedicales.fr/mesh/D017781",
"about": {
"@type": "MedicalCondition",
"name": "Gènes précoces",
"code": {
"@type": "MedicalCode",
"code": "D017781",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.358.840.500.345"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Gènes de particule intracisternale de type A",
"alternateName": "Genes, Intracisternal A-Particle",
"url": "https://questionsmedicales.fr/mesh/D007426",
"about": {
"@type": "MedicalCondition",
"name": "Gènes de particule intracisternale de type A",
"code": {
"@type": "MedicalCode",
"code": "D007426",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.358.840.500.360"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Gènes nef",
"alternateName": "Genes, nef",
"url": "https://questionsmedicales.fr/mesh/D015754",
"about": {
"@type": "MedicalCondition",
"name": "Gènes nef",
"code": {
"@type": "MedicalCode",
"code": "D015754",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.358.840.500.600"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Gènes pol",
"alternateName": "Genes, pol",
"url": "https://questionsmedicales.fr/mesh/D015751",
"about": {
"@type": "MedicalCondition",
"name": "Gènes pol",
"code": {
"@type": "MedicalCode",
"code": "D015751",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.358.840.500.667"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Gènes pX",
"alternateName": "Genes, pX",
"url": "https://questionsmedicales.fr/mesh/D016355",
"about": {
"@type": "MedicalCondition",
"name": "Gènes pX",
"code": {
"@type": "MedicalCode",
"code": "D016355",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.358.840.500.735"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Gènes rev",
"alternateName": "Genes, rev",
"url": "https://questionsmedicales.fr/mesh/D015757",
"about": {
"@type": "MedicalCondition",
"name": "Gènes rev",
"code": {
"@type": "MedicalCode",
"code": "D015757",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.358.840.500.775"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Gènes tat",
"alternateName": "Genes, tat",
"url": "https://questionsmedicales.fr/mesh/D015756",
"about": {
"@type": "MedicalCondition",
"name": "Gènes tat",
"code": {
"@type": "MedicalCode",
"code": "D015756",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.358.840.500.850"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Gènes vif",
"alternateName": "Genes, vif",
"url": "https://questionsmedicales.fr/mesh/D016341",
"about": {
"@type": "MedicalCondition",
"name": "Gènes vif",
"code": {
"@type": "MedicalCode",
"code": "D016341",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.358.840.500.890"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Gènes vpr",
"alternateName": "Genes, vpr",
"url": "https://questionsmedicales.fr/mesh/D016334",
"about": {
"@type": "MedicalCondition",
"name": "Gènes vpr",
"code": {
"@type": "MedicalCode",
"code": "D016334",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.358.840.500.897"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Gènes vpu",
"alternateName": "Genes, vpu",
"url": "https://questionsmedicales.fr/mesh/D016338",
"about": {
"@type": "MedicalCondition",
"name": "Gènes vpu",
"code": {
"@type": "MedicalCode",
"code": "D016338",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.358.840.500.900"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Génome viral",
"alternateName": "Genome, Viral",
"code": {
"@type": "MedicalCode",
"code": "D016679",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Kiramage Chathuranga",
"url": "https://questionsmedicales.fr/author/Kiramage%20Chathuranga",
"affiliation": {
"@type": "Organization",
"name": "College of Veterinary Medicine, Chungnam National University, Daejeon, 34134, Korea."
}
},
{
"@type": "Person",
"name": "Jong-Soo Lee",
"url": "https://questionsmedicales.fr/author/Jong-Soo%20Lee",
"affiliation": {
"@type": "Organization",
"name": "College of Veterinary Medicine, Chungnam National University, Daejeon, 34134, Korea. jongsool@cnu.ac.kr."
}
},
{
"@type": "Person",
"name": "Alfred A Antson",
"url": "https://questionsmedicales.fr/author/Alfred%20A%20Antson",
"affiliation": {
"@type": "Organization",
"name": "York Structural Biology Laboratory, Department of Chemistry, University of York, York, UK. fred.antson@york.ac.uk."
}
},
{
"@type": "Person",
"name": "Stephen S-T Yau",
"url": "https://questionsmedicales.fr/author/Stephen%20S-T%20Yau",
"affiliation": {
"@type": "Organization",
"name": "Department of Mathematical Sciences, Tsinghua University, Beijing, 100084, People's Republic of China."
}
},
{
"@type": "Person",
"name": "Anouk Willemsen",
"url": "https://questionsmedicales.fr/author/Anouk%20Willemsen",
"affiliation": {
"@type": "Organization",
"name": "Laboratory MIVEGEC (UMR CNRS IRD University of Montpellier), Centre National de la Recherche Scientifique (CNRS), 911 Avenue Agropolis, BP 64501, 34394 Montpellier cedex 5, France."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Impact of formulation design and lyophilisation on the physicochemical characteristics of finasteride nanosystems.",
"datePublished": "2023-02-24",
"url": "https://questionsmedicales.fr/article/36749573",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/02652048.2023.2178537"
}
},
{
"@type": "ScholarlyArticle",
"name": "A prospective evaluation of the effect of finasteride on prostate health index (phi).",
"datePublished": "2023-03-01",
"url": "https://questionsmedicales.fr/article/36856925",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11255-023-03530-3"
}
},
{
"@type": "ScholarlyArticle",
"name": "Comparison of oral minoxidil, finasteride, and dutasteride for treating androgenetic alopecia.",
"datePublished": "2022-08-15",
"url": "https://questionsmedicales.fr/article/35920739",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/09546634.2022.2109567"
}
},
{
"@type": "ScholarlyArticle",
"name": "Evaluation of the therapeutic effects of AGA drugs by measuring finasteride, dutasteride, and dihydrotestosterone in hair.",
"datePublished": "2023-06-28",
"url": "https://questionsmedicales.fr/article/37385468",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.cca.2023.117456"
}
},
{
"@type": "ScholarlyArticle",
"name": "Physicochemical Characterization of Chitosan-Decorated Finasteride Solid Lipid Nanoparticles for Skin Drug Delivery.",
"datePublished": "2022-08-06",
"url": "https://questionsmedicales.fr/article/35971450",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1155/2022/7792180"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes génétiques",
"item": "https://questionsmedicales.fr/mesh/D055614"
},
{
"@type": "ListItem",
"position": 3,
"name": "Structures génétiques",
"item": "https://questionsmedicales.fr/mesh/D040342"
},
{
"@type": "ListItem",
"position": 4,
"name": "Génome",
"item": "https://questionsmedicales.fr/mesh/D016678"
},
{
"@type": "ListItem",
"position": 5,
"name": "Génome microbien",
"item": "https://questionsmedicales.fr/mesh/D064349"
},
{
"@type": "ListItem",
"position": 6,
"name": "Génome viral",
"item": "https://questionsmedicales.fr/mesh/D016679"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Génome viral - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Génome viral",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-17",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Génome viral",
"description": "Comment détecte-t-on un génome viral ?\nQuels tests sont utilisés pour le génome viral ?\nPeut-on séquencer un génome viral ?\nQuels symptômes indiquent une infection virale ?\nComment différencier les virus par leur génome ?",
"url": "https://questionsmedicales.fr/mesh/D016679?mesh_terms=Finasteride#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Génome viral",
"description": "Quels sont les symptômes d'une infection virale ?\nLes symptômes varient-ils selon le virus ?\nComment les symptômes évoluent-ils ?\nLes symptômes sont-ils toujours présents ?\nQuels symptômes indiquent une complication ?",
"url": "https://questionsmedicales.fr/mesh/D016679?mesh_terms=Finasteride#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Génome viral",
"description": "Comment prévenir les infections virales ?\nLes vaccins sont-ils efficaces contre tous les virus ?\nQuelles mesures de santé publique aident à prévenir les épidémies ?\nLe port de masque aide-t-il à prévenir les infections ?\nLes voyages augmentent-ils le risque d'infection virale ?",
"url": "https://questionsmedicales.fr/mesh/D016679?mesh_terms=Finasteride#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Génome viral",
"description": "Quels traitements existent pour les infections virales ?\nLes antibiotiques sont-ils efficaces contre les virus ?\nComment les antiviraux agissent-ils ?\nLes traitements varient-ils selon le virus ?\nLes vaccins préviennent-ils toutes les infections virales ?",
"url": "https://questionsmedicales.fr/mesh/D016679?mesh_terms=Finasteride#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Génome viral",
"description": "Quelles sont les complications possibles d'une infection virale ?\nComment les complications sont-elles traitées ?\nLes complications sont-elles fréquentes ?\nLes personnes âgées sont-elles plus à risque de complications ?\nComment prévenir les complications ?",
"url": "https://questionsmedicales.fr/mesh/D016679?mesh_terms=Finasteride#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Génome viral",
"description": "Quels sont les facteurs de risque d'infection virale ?\nLe mode de vie influence-t-il le risque d'infection ?\nLes maladies chroniques augmentent-elles le risque ?\nLes voyages à l'étranger augmentent-ils le risque ?\nLes contacts fréquents avec des malades augmentent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D016679?mesh_terms=Finasteride#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment détecte-t-on un génome viral ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "On utilise des techniques comme la PCR pour identifier le matériel génétique viral."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le génome viral ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests sérologiques et les tests moléculaires sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Peut-on séquencer un génome viral ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le séquençage permet d'analyser la structure du génome viral."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une infection virale ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, fatigue, toux et douleurs musculaires peuvent signaler une infection virale."
}
},
{
"@type": "Question",
"name": "Comment différencier les virus par leur génome ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'analyse du type d'acide nucléique (ADN ou ARN) aide à classer les virus."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une infection virale ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fièvre, toux, fatigue, et parfois éruptions cutanées."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le virus ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chaque virus peut provoquer des symptômes spécifiques selon son type."
}
},
{
"@type": "Question",
"name": "Comment les symptômes évoluent-ils ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent s'aggraver ou s'améliorer selon la réponse immunitaire."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils toujours présents ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, certains virus peuvent être asymptomatiques chez certaines personnes."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une complication ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des difficultés respiratoires ou des douleurs thoraciques peuvent signaler des complications."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections virales ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Se laver les mains, éviter les contacts étroits et se faire vacciner sont essentiels."
}
},
{
"@type": "Question",
"name": "Les vaccins sont-ils efficaces contre tous les virus ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, chaque vaccin cible des virus spécifiques et n'offre pas une protection universelle."
}
},
{
"@type": "Question",
"name": "Quelles mesures de santé publique aident à prévenir les épidémies ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "La surveillance épidémiologique et la vaccination de masse sont cruciales."
}
},
{
"@type": "Question",
"name": "Le port de masque aide-t-il à prévenir les infections ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le port de masque réduit la transmission des virus respiratoires."
}
},
{
"@type": "Question",
"name": "Les voyages augmentent-ils le risque d'infection virale ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les voyages peuvent faciliter la propagation des virus d'une région à une autre."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour les infections virales ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antiviraux, les traitements symptomatiques et les vaccins sont utilisés."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils efficaces contre les virus ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les antibiotiques ne sont pas efficaces contre les infections virales."
}
},
{
"@type": "Question",
"name": "Comment les antiviraux agissent-ils ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils inhibent la réplication virale ou bloquent l'entrée du virus dans les cellules."
}
},
{
"@type": "Question",
"name": "Les traitements varient-ils selon le virus ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chaque virus peut nécessiter un traitement spécifique adapté."
}
},
{
"@type": "Question",
"name": "Les vaccins préviennent-ils toutes les infections virales ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les vaccins ne couvrent pas tous les virus, mais protègent contre certains."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles d'une infection virale ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure pneumonie, encéphalite ou défaillance organique."
}
},
{
"@type": "Question",
"name": "Comment les complications sont-elles traitées ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement dépend de la complication, souvent avec des soins de soutien."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles fréquentes ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Cela dépend du virus et de l'état de santé de l'individu, certaines infections sont plus risquées."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus à risque de complications ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées ont un risque accru de complications graves lors d'infections virales."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic précoce et un traitement approprié peuvent réduire le risque de complications."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque d'infection virale ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, l'immunodépression et l'exposition à des personnes infectées."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le risque d'infection ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sain peut réduire le risque d'infections virales."
}
},
{
"@type": "Question",
"name": "Les maladies chroniques augmentent-elles le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les maladies chroniques peuvent affaiblir le système immunitaire et augmenter le risque."
}
},
{
"@type": "Question",
"name": "Les voyages à l'étranger augmentent-ils le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des zones à forte incidence de virus peut accroître le risque d'infection."
}
},
{
"@type": "Question",
"name": "Les contacts fréquents avec des malades augmentent-ils le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, être en contact étroit avec des personnes infectées augmente le risque d'infection."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 12/04/2025
Contenu vérifié selon les dernières recommandations médicales
└─
Gènes viraux
Genes, Viral
D005814
-
G05.360.340.358.840.500
└─└─
Gènes env
Genes, env
D015752
-
G05.360.340.358.840.500.172
└─└─
Gènes gag
Genes, gag
D015750
-
G05.360.340.358.840.500.258
└─└─
Gènes précoces
Genes, Immediate-Early
D017781
-
G05.360.340.358.840.500.345
└─└─
Gènes de particule intracisternale de type A
Genes, Intracisternal A-Particle
D007426
-
G05.360.340.358.840.500.360
└─└─
Gènes nef
Genes, nef
D015754
-
G05.360.340.358.840.500.600
└─└─
Gènes pol
Genes, pol
D015751
-
G05.360.340.358.840.500.667
└─└─
Gènes pX
Genes, pX
D016355
-
G05.360.340.358.840.500.735
└─└─
Gènes rev
Genes, rev
D015757
-
G05.360.340.358.840.500.775
└─└─
Gènes tat
Genes, tat
D015756
-
G05.360.340.358.840.500.850
└─└─
Gènes vif
Genes, vif
D016341
-
G05.360.340.358.840.500.890
└─└─
Gènes vpr
Genes, vpr
D016334
-
G05.360.340.358.840.500.897
└─└─
Gènes vpu
Genes, vpu
D016338
-
G05.360.340.358.840.500.900
2 publications dans cette catégorie
Affiliations :
College of Veterinary Medicine, Chungnam National University, Daejeon, 34134, Korea.
Publications dans "Génome viral" :
2 publications dans cette catégorie
Affiliations :
College of Veterinary Medicine, Chungnam National University, Daejeon, 34134, Korea. jongsool@cnu.ac.kr.
Publications dans "Génome viral" :
2 publications dans cette catégorie
Affiliations :
York Structural Biology Laboratory, Department of Chemistry, University of York, York, UK. fred.antson@york.ac.uk.
Structural Biology, The Francis Crick Institute, London, UK. fred.antson@york.ac.uk.
Publications dans "Génome viral" :
2 publications dans cette catégorie
Affiliations :
Department of Mathematical Sciences, Tsinghua University, Beijing, 100084, People's Republic of China.
Beijing Institute of Mathematical Sciences and Applications (Bimsa), Beijing, 101408, People's Republic of China.
Publications dans "Génome viral" :
2 publications dans cette catégorie
Affiliations :
Laboratory MIVEGEC (UMR CNRS IRD University of Montpellier), Centre National de la Recherche Scientifique (CNRS), 911 Avenue Agropolis, BP 64501, 34394 Montpellier cedex 5, France.
Publications dans "Génome viral" :
2 publications dans cette catégorie
Affiliations :
Netherlands Institute of Ecology (NIOO-KNAW), Postbus 50, 6700 AB, Wageningen, The Netherlands.
Publications dans "Génome viral" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora, CO, United States. Electronic address: carlos.catalano@cuanschutz.edu.
Publications dans "Génome viral" :
2 publications dans cette catégorie
Affiliations :
Department of Biochemistry and Molecular Biology, Sealy Center for Structural and Molecular Biophysics, University of Texas Medical Branch at Galveston, Galveston, TX, United States.
Publications dans "Génome viral" :
2 publications dans cette catégorie
Affiliations :
Department of Biological Sciences, Grambling State University, Grambling, LA.
Publications dans "Génome viral" :
2 publications dans cette catégorie
Affiliations :
Department of Biological Sciences, Grambling State University, Grambling, LA.
Publications dans "Génome viral" :
2 publications dans cette catégorie
Affiliations :
School of Biological Sciences, Louisiana Tech University, Ruston, LA.
Publications dans "Génome viral" :
2 publications dans cette catégorie
Affiliations :
Burnett School of Biomedical Sciences, University of Central Florida, Orlando, FL.
Publications dans "Génome viral" :
2 publications dans cette catégorie
Affiliations :
Physics and Chemistry Programs, Louisiana Tech University, Ruston, LA.
Publications dans "Génome viral" :
2 publications dans cette catégorie
Affiliations :
Mercer University School of Medicine, Macon, GA.
Publications dans "Génome viral" :
2 publications dans cette catégorie
Affiliations :
Mercer University School of Medicine, Macon, GA.
Publications dans "Génome viral" :
2 publications dans cette catégorie
Affiliations :
Mercer University School of Medicine, Macon, GA.
Publications dans "Génome viral" :
2 publications dans cette catégorie
Affiliations :
Mercer Medicine, Macon, GA.
Publications dans "Génome viral" :
2 publications dans cette catégorie
Affiliations :
Mercer Medicine, Macon, GA.
Publications dans "Génome viral" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, Jackson State University, Jackson, MS.
Publications dans "Génome viral" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, Jackson State University, Jackson, MS.
Publications dans "Génome viral" :
The fundamental purpose of this study was to develop a stable lyophilised finasteride nanosystem (FNS-NS) for topical delivery. The FNS-NS was fabricated using an ultrasonication technique. The impact...
5-alpha reductase inhibitor (5ARI) reduces prostate-specific antigen (PSA) by half but its effect on prostate health index (phi) is unknown. This study aims to investigate this effect and to enable ac...
This is a prospective study evaluating the effect of finasteride on PSA, free PSA (fPSA), [ - 2]proPSA (p2PSA) and phi at 6 and 12 moths in men with PSA 4-20 ng/mL, no prior 5ARI use, and one negative...
164 men fit the inclusion criteria and 150 were analyzed. In 5ARI group (n = 100) at 1 year, mean PSA reduced by 51.4% from 8.9(± SD 3.7) to 4.4(± SD 2.8)ng/mL (paired t-test, p < 0.001), fPSA reduced...
This study demonstrated p2PSA and phi are reduced by about 55% and 34% in men on 5ARI. A conversion factor of division by 0.66 is needed for phi in men on finasteride to allow the interpretation and u...
Androgenetic alopecia (AGA) is the most common cause of hair loss, often challenging to treat. While oral finasteride (1 mg/d) is an FDA-approved treatment for male AGA, oral minoxidil and oral dutast...
A probable efficacy ranking, in decreasing order, is - dutasteride 0.5 mg/d, finasteride 5 mg/d, minoxidil 5 mg/d, finasteride 1 mg/d, followed by minoxidil 0.25 mg/d. Oral minoxidil predominantly cau...
The average plasma half-lives of minoxidil, finasteride, and dutasteride are ∼4 h, ∼4.5 h, and ∼5 weeks, respectively. Minoxidil acts through multiple pathways to promote hair growth. It has been show...
Androgenetic alopecia (AGA) is treated by 5α-reductase inhibitors (5ARI) such as finasteride and dutasteride, which are widely used as therapeutic agents. However, their pharmacokinetics in target org...
To confirm the effective action of finasteride and dutasteride in the hair follicle tissues, we developed a method to measure these concentrations in hair....
Compared to the non-detection (N.D.) group, the dihydrotestosterone (DHT) concentrations decreased significantly in both the finasteride and dutasteride groups. The dutasteride group showed significan...
Measurement of finasteride, dutasteride, and DHT concentrations in hair would aid in evaluating the drug pharmacokinetics and its therapeutic effects on AGA patients....
Finasteride is considered the drug of choice for androgenic alopecia and benign prostate hyperplasia. The aim of the study was to formulate nanodrug carriers of finasteride with enhanced retentive pro...
Gut microbes are closely associated with disease onset and improvement. However, the effects of gut microbes on the occurrence, prevention, and treatment of benign prostatic hyperplasia (BPH) are stil...
Androgen suppression therapy has been associated with a lower incidence of bladder cancer (BCa) or improved overall/cancer-specific survival. Results are ofent conflicting; therefore, we aim to assess...
The South Texas Veterans Healthcare System from 5 medical centers was queried for patients with BCa with or without use of finasteride after diagnosis of BCa. The primary outcome was the impact of fin...
A total of 1890 patients were included, amongst which 619 (32.8%) men were classified as finasteride users and 1271 (67.2%) men as controls. At a median (IQR) follow up of 53.8 (27.4, 90.9) months, de...
Finasteride use is associated with the improved overall survival in patients with BCa, specifically in patients with NMIBC. We, further, propose a randomized clinical trial to investigate the use of f...
Herein, we report nanogels comprising diverse feed ratio of polymer hydroxypropyl methylcellulose (HPMC), monomer acrylic acid (AA), and cross-linker methylene bisacrylamide (MBA) fabricated for trans...
LDOM has enhanced treatment options for female AGA, yet its combined efficacy with therapies such as spironolactone, finasteride, or dutasteride remains inadequately explored. This study aims to compa...
Benign prostatic hyperplasia (BPH) may decrease patient quality of life and often leads to acute urinary retention and surgical intervention. While effective treatments are available, many BPH patient...